Pralidoxime

Table of contents

  • Brand Names
  • Drug Combinations
  • Chemistry
  • Pharmacologic Category
  • Mechanism of Action
  • Therapeutic Use
  • Unlabeled Use
  • Pregnancy and Lactation Implications
  • Contraindications
  • Warnings and Precautions
  • Adverse Reactions
  • Genes that may be involved
  • Drug Interactions
  • Dosage
  • Pharmacokinetics and Pharmacodynamics
  • Special Considerations

Brand Names

Europe

France: Contrathion, Ineurope; Greece: Contrathion, Helpoxime.

North America

USA: Pralidoxime, Protopam.

Latin America

Argentina: Contrathion; Brazil: Contrathion.

Asia

Japan: Pam.

Drug combinations

Pralidoxime and Atropine

Chemistry

Pralidoxime Chloride: C~7~H~9~ClN~2~O. Mw: 172.61. (1) Pyridinium, 2-[(hydroxyimino)methyl]-1-methyl-, chloride; (2) 2-Formyl-1-methylpyridinium chloride oxime. CAS-51-15-0 (1962).

Pharmacologic Category

Antidotes. (ATC-Code: V03AB04).

Mechanism of action

Reactivates cholinesterase inactivated by phosphorylation due to exposure to organophosphate pesticides, by displacing enzyme from its receptor sites.

Therapeutic use

Reversal of muscle paralysis caused by toxic exposure to organophosphate anticholinesterase pesticides and chemicals. Control of overdose of anticholinesterase medications used to treat myasthenia gravis (ambenonium, neostigmine, pyridostigmine).

Pregnancy and lactiation implications

Caution advised during pregnancy or lactation.

Unlabeled use

Treatment of nerve agent toxicity (chemical warfare) in combination with atropine.

Contraindications

Hypersensitivity to pralidoxime or any component of the formulation. Poisoning due to phosphorus, inorganic phosphates, or organic phosphates without anticholinesterase activity. Poisoning due to pesticides of carbamate class (may increase toxicity of carbaryl).

Warnings and precautions

Use with caution in myasthenia gravis, and in renal impairment. Pralidoxime most effective when given immediately after poisoning. Antidotal administration intended only for initial management.

Information

Legal

Legal Notice
Privacy Policy
Cookie Policy

Contact

Phone: +34-981-780505
Email: genomicmedicine@wagem.org
Location: Sta Marta de, C. P. Babío, S/N, 15165 Bergondo, A Coruña

Copyright © 2023 WAGEM

Add to cart